Skip to menu Skip to content Skip to footer
Dr Luis Furuya Kanamori
Dr

Luis Furuya Kanamori

Email: 

Overview

Background

Dr Luis Furuya Kanamori MBBS, MEpi, MPH, PhD, FACTM is a clinical epidemiologist and research synthesis methodologist. He is an international leader in travel medicine, vaccine preventable diseases, and research synthesis, and has been listed in Stanford University’s World top 2% of scientists.

Dr Furuya Kanamori leads the Travel Medicine and Vaccine Preventable Diseases Theme, and the Clinician-Epidemiologist Hub at UQ's HERA program on Operational Research and Decision Support for Infectious Diseases (ODeSI). He is Director of Research of the Clinical Research & Evidence Synthesis (CRESTMA) at the Travel Medicine Alliance (TMA), network of 30+ travel medicine clinics in Australia.

Dr Furuya Kanamori’s applied research on travel medicine and vaccine preventable diseases has influenced key changes in clinical and public health guidelines (e.g., WHO, ATAGI, Australian Immunisation Handbook, UptoDate). His methodological work on publication bias (LFK index) has been implemented in MetaXL, Stata, and R, and has been utilised in 800+ published meta-analyses.

In addition to his academic roles, Dr Furuya Kanamori is editorial board member for J Travel Med and Clin Infect Dis, and chairs the Research and Awards Committee of the International Society of Travel Medicine.

Availability

Dr Luis Furuya Kanamori is:
Available for supervision

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, Universidad Peruana Cayetano Heredia
  • Masters (Coursework) of Epidemiology, The University of Queensland
  • Masters (Coursework) of Public Health, The University of Queensland
  • Doctor of Philosophy, Australian National University

Research interests

  • Travel Medicine

    Vaccine fractional dosing | Malaria chemoprophylaxis | STIs | Causes of death | Decision support systems | Personalised risk assessment | Clinical trials

  • Vaccine preventable diseases

    Rabies PrEP and PEP | Japanese encephalitis | Yellow fever | Vaccine safety

  • Research synthesis and meta-analysis

    Publication bias | Diagnostic accuracy studies | Quality information | Rare/zero-events studies | Rapid meta-analysis

Works

Search Professor Luis Furuya Kanamori’s works on UQ eSpace

157 works between 2013 and 2024

21 - 40 of 157 works

2023

Journal Article

The SMART Safety: an empirical dataset for evidence synthesis of adverse events

Fan, Shiqi, Yu, Tianqi, Yang, Xi, Zhang, Rui, Furuya-Kanamori, Luis and Xu, Chang (2023). The SMART Safety: an empirical dataset for evidence synthesis of adverse events. Data in Brief, 51 109639, 1-7. doi: 10.1016/j.dib.2023.109639

The SMART Safety: an empirical dataset for evidence synthesis of adverse events

2023

Journal Article

A health survey revealing prevalence of vector-borne diseases and tuberculosis in Papua New Guinea Defence Force personnel and families

McCallum, Fiona, Mond, Krond, Cheng, Qin, Furuya-Kanamori, Luis, Auliff, Alyson, Kaminiel, Peter and ADFMIDI/PNGDF Health Services Survey Team for the ADFMIDI/PNGDF Health Services Survey Team (2023). A health survey revealing prevalence of vector-borne diseases and tuberculosis in Papua New Guinea Defence Force personnel and families. The American Journal of Tropical Medicine and Hygiene, 109 (5), 1086-1094. doi: 10.4269/ajtmh.23-0341

A health survey revealing prevalence of vector-borne diseases and tuberculosis in Papua New Guinea Defence Force personnel and families

2023

Journal Article

Data extraction error in pharmaceutical versus non-pharmaceutical interventions for evidence synthesis: Study protocol for a crossover trial

Zhu, Yi, Ren, Pengwei, Doi, Suhail A.R., Furuya-Kanamori, Luis, Lin, Lifeng, Zhou, Xiaoqin, Tao, Fangbiao and Xu, Chang (2023). Data extraction error in pharmaceutical versus non-pharmaceutical interventions for evidence synthesis: Study protocol for a crossover trial. Contemporary Clinical Trials Communications, 35 101189, 1-6. doi: 10.1016/j.conctc.2023.101189

Data extraction error in pharmaceutical versus non-pharmaceutical interventions for evidence synthesis: Study protocol for a crossover trial

2023

Journal Article

Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers

Guo, Yihan, Mills, Deborah J., Lau, Colleen L., Mills, Christine and Furuya‐Kanamori, Luis (2023). Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers. Zoonoses and Public Health, 70 (6), 465-472. doi: 10.1111/zph.13048

Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers

2023

Journal Article

A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers

Lau, Colleen L., Mills, Deborah J., Mayfield, Helen, Gyawali, Narayan, Johnson, Brian J., Lu, Hongen, Allel, Kasim, Britton, Philip N., Ling, Weiping, Moghaddam, Tina and Furuya-Kanamori, Luis (2023). A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers. Journal of Travel Medicine, 30 (7) taad113. doi: 10.1093/jtm/taad113

A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers

2023

Journal Article

The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis

Allel, Kasim, Stone, Jennifer, Undurraga, Eduardo A., Day, Lucy, Moore, Catrin E., Lin, Leesa, Furuya-Kanamori, Luis and Yakob, Laith (2023). The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis. PLoS Medicine, 20 (6) e1004199, 1-34. doi: 10.1371/journal.pmed.1004199

The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis

2023

Journal Article

Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019

Laupland, Kevin B., Edwards, Felicity, Furuya-Kanamori, Luis, Paterson, David L. and Harris, Patrick N. A. (2023). Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019. The American Journal of Medicine, 136 (9), 896-901. doi: 10.1016/j.amjmed.2023.05.003

Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019

2023

Journal Article

Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface

Allel, Kasim, Day, Lucy, Hamilton, Alisa, Lin, Leesa, Furuya-Kanamori, Luis, Moore, Catrin E, Van Boeckel, Thomas, Laxminarayan, Ramanan and Yakob, Laith (2023). Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface. The Lancet Planetary Health, 7 (4), e291-e303. doi: 10.1016/S2542-5196(23)00026-8

Global antimicrobial-resistance drivers: an ecological country-level study at the human–animal interface

2023

Journal Article

The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses

Liu, Ziyu, Al Amer, Fahad M., Xiao, Mengli, Xu, Chang, Furuya-Kanamori, Luis, Hong, Hwanhee, Siegel, Lianne and Lin, Lifeng (2023). The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses. BMC Medicine, 21 (1) 112, 1-12. doi: 10.1186/s12916-023-02823-9

The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses

2023

Journal Article

An empirical comparison of the harmful effects for randomized controlled trials and non-randomized studies of interventions

Dai, Minhan, Furuya-Kanamori, Luis, Syed, Asma, Lin, Lifeng and Wang, Qiang (2023). An empirical comparison of the harmful effects for randomized controlled trials and non-randomized studies of interventions. Frontiers in Pharmacology, 14 1064567, 1-8. doi: 10.3389/fphar.2023.1064567

An empirical comparison of the harmful effects for randomized controlled trials and non-randomized studies of interventions

2023

Journal Article

Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi)

Xu, Chang, Furuya-Kanamori, Luis, Lin, Lifeng, Zorzela, Liliane, Yu, Tianqi and Vohra, Sunita (2023). Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi). BMC Medical Research Methodology, 23 (1) 61, 1-9. doi: 10.1186/s12874-023-01884-x

Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi)

2023

Journal Article

Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia from 2000 to 2019

Ling, Weiping, Paterson, David L., Harris, Patrick N. A., Furuya-Kanamori, Luis, Edwards, Felicity and Laupland, Kevin B. (2023). Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia from 2000 to 2019. Open Forum Infectious Diseases, 10 (3) ofad071, ofad071. doi: 10.1093/ofid/ofad071

Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia from 2000 to 2019

2023

Journal Article

Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine

Furuya-Kanamori, Luis, Gyawali, Narayan, Mills, Deborah J., Mills, Christine, Hugo, Leon E, Devine, Gregor J. and Lau, Colleen L. (2023). Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine. Journal of Travel Medicine, 30 (2) taac122, 1-8. doi: 10.1093/jtm/taac122

Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine

2023

Conference Publication

Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis

Ling, Weiping, Cadavid-Restrepo, Angela, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2023). Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis. 10th International Congress of the Asia Pacific Society of Infection Control 2022 (APSIC 2022), Singapore, 28 - 31 July 2022. Cambridge, United Kingdom: Cambridge University Press. doi: 10.1017/ash.2023.71

Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis

2023

Journal Article

Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence

Rafferty, Anna C., Bofkin, Kelly, Hughes, Whitney, Souter, Sara, Hosegood, Ian, Hall, Robyn N., Furuya-Kanamori, Luis, Liu, Bette, Drane, Michael, Regan, Toby, Halder, Molly, Kelaher, Catherine and Kirk, Martyn D. (2023). Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence. PLoS One, 18 (2) e0264294, 1-18. doi: 10.1371/journal.pone.0264294

Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence

2022

Journal Article

Data reproducibility issues and their potential impact on conclusions from evidence syntheses of randomized controlled trials in sleep medicine

Xu, Chang, Doi, Suhail A.R., Zhou, Xiaoqin, Lin, Lifeng, Furuya-Kanamori, Luis and Tao, Fangbiao (2022). Data reproducibility issues and their potential impact on conclusions from evidence syntheses of randomized controlled trials in sleep medicine. Sleep Medicine Reviews, 66 101708, 1-8. doi: 10.1016/j.smrv.2022.101708

Data reproducibility issues and their potential impact on conclusions from evidence syntheses of randomized controlled trials in sleep medicine

2022

Journal Article

β-lactam-resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis

Griskaitis, Matas, Furuya-Kanamori, Luis, Allel, Kasim, Stabler, Richard, Harris, Patrick, Paterson, David L. and Yakob, Laith (2022). β-lactam-resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis. Clinical Infectious Diseases, 75 (11), 1962-1970. doi: 10.1093/cid/ciac293

β-lactam-resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis

2022

Journal Article

Does the sex of the firstborn child affect the breast cancer risk and survival: a systematic review and meta-analysis of over 1 million cases

Thalib, Lukman, Doi, Suhail A. R., Daher-Nashif, Suhad, Kane, Tanya and Furuya-Kanamori, Luis (2022). Does the sex of the firstborn child affect the breast cancer risk and survival: a systematic review and meta-analysis of over 1 million cases. Balkan Medical Journal, 39 (6), 429-435. doi: 10.4274/balkanmedj.galenos.2022.2022-5-54

Does the sex of the firstborn child affect the breast cancer risk and survival: a systematic review and meta-analysis of over 1 million cases

2022

Journal Article

Should studies with no events in both arms be excluded in evidence synthesis?

Xu, Chang, Furuya-Kanamori, Luis, Islam, Nazmul and Doi, Suhail A. (2022). Should studies with no events in both arms be excluded in evidence synthesis?. Contemporary Clinical Trials, 122 106962, 1-8. doi: 10.1016/j.cct.2022.106962

Should studies with no events in both arms be excluded in evidence synthesis?

2022

Journal Article

Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis

Ling, Weiping, Cadavid-Restrepo, Angela, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis. Epidemiology and Infection, 150 e178, 1-27. doi: 10.1017/s0950268822001637

Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis

Funding

Current funding

  • 2024 - 2025
    JEV IgM persistence following vaccination
    Queensland Health
    Open grant

Past funding

  • 2023 - 2024
    Development of a protocol for defining and identifying high-threat 1 pathogens to support WHO STAR HTP risk assessments in the Southeast Asia Region
    World Health Organisation South-East Asia Regional Office
    Open grant
  • 2022 - 2024
    Japanese Encephalitis Vaccine Risk-Benefit Analysis Tool (International Society of Travel Medicine grant administered by Dr Deb The Travel Doctor)
    Dr Deb The Travel Doctor Pty Ltd
    Open grant
  • 2021 - 2023
    JEVID - Japanese Encephalitis Vaccination via IntraDermal route
    The International Society of Travel Medicine Research Grant
    Open grant
  • 2021 - 2023
    Reducing the risk of importing multidrug resistant enterobacteriaceae into Australia
    NHMRC Early Career Fellowships
    Open grant

Supervision

Availability

Dr Luis Furuya Kanamori is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Vaccine preventable diseases in travellers

  • Causes of death in travellers

  • Risk benefit analysis and decision support tools for vaccines

  • Advancements in research synthesis methods and meta-analyses

Supervision history

Current supervision

  • Doctor Philosophy

    Assessing risk of importation of sexually transmitted infections into Australia by international travellers

    Principal Advisor

    Other advisors: Professor Colleen Lau, Associate Professor Judith Dean

  • Doctor Philosophy

    Machine learning in epidemiology research on African Swine Fever epidemic in the Philippines Outline

    Associate Advisor

    Other advisors: Professor Colleen Lau

Completed supervision

Media

Enquiries

For media enquiries about Dr Luis Furuya Kanamori's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au